Andrew Braverman
Studies in Business Administration from University of Delaware. Currently working as Chief Operating Officer at Innovative Turnaround Controls.
| Headline: | Entrepreneur |
| Website: | http://www.sharpcp.com |
| Skills: | Business, Management, Marketing |
| Location: | Houston, TX |
| Interested in: | Brainstorming, Finding business partners, Finding cofounders, Finding team mates, Meeting new people, Professional opportunities, Promoting my startups, Recruiting for my startup |
| Schools: | University of Delaware |
WORK EXPERIENCE
| Employer: | Innovative Turnaround Controls (ITC) – Houston, TX |
| Position: | Chief Operating Officer |
| Time period: | December 2007 - November 2009 |
| Description: | ITC ($15 million in annual revenue) is a long-term solution provider that helps clients reduce year-to-year project controls costs of shutdowns, turnarounds, and capitol projects through planning, estimating, scheduling and contractor coordination in the petrochemical/chemical refinery industry.
Oversaw operations for three companies owned by parent company ITC (Toadfly Technologies, Core Engineering, and Complete Recruiting Solutions) while managing over 200 employees across the U.S. and in India. Developed and implemented operational strategic plans, which included development efforts for new and innovative technologies. Assisted the CEO by defining, translating and executing vision and corporate goals into effective operational objectives. Analyzed cost impact of internal processes and instituted changes where necessary to generate cost savings. - Reduced overall operating cost by 20% while increasing 4th quarter sales to the highest on record for the company since it’s inception. - Initiated transfer of all accounting functions in-house, which reduced accounting costs by 40%. - Spearheaded attainment of the company’s first patent. - Initiated the process for securing new offices in Asia. |
| Employer: | World Prime Financial – Boca Raton, FL |
| Position: | Executive Vice President |
| Time period: | December 2002 - November 2008 |
| Description: | World Prime Financial identifies and supports new and viable entrepreneurial ventures through funding, management, and assistance with establishment of long-term company planning and vision.
Developed and executed tactical plans to meet business plan goals and objectives. Oversaw all aspects of leading startup ventures, which included strategic planning, budgeting, funds acquisition, strategic alliance development, marketing, sales, operations, human resources and fiscal management. Launched Energis Petroleum, a venture designed to acquire and grow a chain of gasoline “super stations”. Led execution of growth strategy by identifying acquisitions, performing due diligence, negotiating agreements, raising working capital and providing overall fiscal management. – Raised $2.5 million in investment capital; acquired three super stations and added new fast food services into two stations. – Exceeded business plan projections and targets by producing $14 million in revenue and $1 million EBITDA in the first year with current assets valued at $10 million. – Led company on a track to acquire seven additional stations over five years, with growth to $40 million with up to $5 million EBITDA. |
| Employer: | Medasorb Technologies (Formerly Renal Tech International) – New York, NY |
| Position: | President and CEO |
| Time period: | December 1995 - November 2003 |
| Description: | Directed efforts to commercialize polymer technology worldwide for use in the medical field for a company that has gone public and now trades under the symbol MSBT.OB. Led negotiations of all domestic/international licensing and joint venture agreements to secure and protect intellectual property portfolio. Recruited and hired world-class team of scientists and business leaders. Secured funding and oversaw product and go-to-market strategies. Built a staff to over 100 professionals.
- Closed agreements with over 300 shareholders to acquire $65 million in working capital from private and institutional investors; successfully secured $2 million NIH Grant. - Secured licensing contract with Fresenius Medical Care, the largest dialysis provider in the world, representing hundred of millions of dollars in potential future revenues and included $10 million value of funding for randomized perspective study. - Expanded technology into additional markets for ESRD, SEPSIS and cardiopulmonary bypass. Successfully oversaw 510k and PMA processes to support FDA and CE approvals. - Built and staffed multiple R&D laboratories and pilot plant to produce resins and support 10,000 patients. Spearheaded implementation of GMP (Good Manufacturing Practices) and pursuit of ISO 9001 registration. - Attracted the premier names of the scientific and medical world, representing notable thought leaders to fill positions on medical and scientific advisory boards. - Credited for securing over 25 patents worldwide. |
| Employer: | White Eagle International Technologies – New York, NY |
| Position: | Managing Director |
| Time period: | December 1992 - November 1996 |
| Description: | Seized entrepreneurial opportunity to secure licenses for Russian medical/scientific technologies and launch commercialization efforts in the United States. Hired delegation of scientists to travel to Russia and identify technologies for potential U.S. commercialization. Successfully negotiated exclusive agreements with eminent Russian scientists. Coordinated patenting of various technologies with patent counsel, and Russian and American scientists. Managed 15 simultaneous projects in ceramic coatings, bioremediation, agricultural products and polymeric resins.
- Raised over $5 million in capital from private investors; shopped projects to Fortune 500 companies and government agencies that included DuPont, GE, 3M, NASA, DOD, and DOE, resulting in successful R&D joint ventures that saved company tens of millions in field study costs, and expedited time-to-market. - Worked directly with Russian Secretary of Science and Technology to initiate first government-sanctioned technology-transfer fund. Appeared on nationally televised documentary on technology transfer in Uzbekistan at the invitation of the Uzbekistan government. - Established and managed relationships with scientific advisory boards at six major universities in the United States. |
EDUCATION
| University: | University of Delaware |
| Degree: | Studies in Business Administration |
PUBLICATIONS
| Articles: | Co-author of five publications relating to human blood detoxification by engineered materials. |
| Patents: | Granted, as co-inventor, U.S. patents 5,904,663 and 6,416,487: “Method of Removing Beta2 Microglobulin from Blood.” |
INFORMATION
| Memberships: | - Young Entrepreneurs’ Organization – New York Chapter
- Medical Device Manufacturers Association - New York Biotechnology Association - New Jersey Center for Biomaterials |
Andrew is Following (2)
View all-
VentureBeat
VentureBeat is a leading business blog that provides news and analysis of technology innovation for forward thinking business executives.
-
SueEasy
SueEasy is on its way to become the de facto tool for online dispute resolution. It empowers the common man to register for free any genuine compliant against a corporation, service or product and seek the best legal representation.